9 03, 2017

CVR Medical Announces Letter of Intent to Acquire Additional Interest

By | March 9th, 2017|Press Release|0 Comments

VANCOUVER, BC / ACCESSWIRE / March 9, 2017 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to report that it has entered into a letter of intent with CVR Global Inc. (“CVR Global”) to acquire an additional 10% interest of the “Joint Venture Business” from CVR Global’s current [...]

23 02, 2017

CVR Medical Announces Financing Closing

By | February 23rd, 2017|Press Release|0 Comments

VANCOUVER, BC / ACCESSWIRE / February 23, 2017 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to report that it has closed its previously announced non-brokered private placement financing for gross proceeds of $2,500,000 (the "Financing"). An aggregate of 7,142,858 units ("Units") were issued at a price of [...]

13 02, 2017

CVR Medical Announces Amended Financing Terms

By | February 13th, 2017|Press Release|0 Comments

VANCOUVER, BC / ACCESSWIRE / February 13, 2017 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") previously announced its intention to complete a private placement financing for gross proceeds of up to $2,500,000 (the "Financing"), which is expected to consist of units, with each unit comprised of one common share [...]

9 02, 2017

CVR Medical Appoints Mr. Benjamin Asuncion to the Board of Directors

By | February 9th, 2017|Press Release|0 Comments

VANCOUVER, BC / ACCESSWIRE / February 9, 2017 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") has appointed Benjamin Asuncion to its Board of Directors. From this position, Mr. Asuncion will serve in capital market advisory and valuation capacities as CVR Medical moves towards market launch. Benjamin Asuncion has over [...]

8 02, 2017

CVR Medical Announces Increase to Previously Announced Financing

By | February 8th, 2017|Press Release|0 Comments

VANCOUVER, BC / ACCESSWIRE / February 7, 2017 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to announce that, due to strong demand, the Company has increased the size of its previously announced private placement financing to 7.58 million units (the “Units”), at a price of $0.33 per [...]

6 02, 2017

CVR Medical Announces Proposed Financing

By | February 6th, 2017|Press Release|0 Comments

VANCOUVER, BC / ACCESSWIRE / February 6, 2017 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces that it intends to complete a private placement financing for gross proceeds of up to $1,250,000 (the "Financing"), which is expected to consist of units, with each unit comprised of one common share [...]

6 02, 2017

CVR Medical Retains DuVal & Associates to Navigate FDA Process

By | February 6th, 2017|Press Release|0 Comments

VANCOUVER, BC / ACCESSWIRE / February 6, 2017 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") has retained the services of DuVal & Associates, P.A., a Minneapolis-based, regulatory law firm focused on counsel within the medical device and pharmaceutical industries. In addition to its strategic advisory role, DuVal & Associates [...]

26 01, 2017

CVR Medical Puts Emphasis on Patents with Cozen O’Connor

By | January 26th, 2017|Press Release|0 Comments

VANCOUVER, BC / ACCESSWIRE / January 26, 2017 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") has retained the services of Cozen O’Connor. The Philadelphia-based law firm will work with CVR to obtain and protect patents related to the technology being implemented in the “Carotid Stenotic Scan (CSS)” device. One [...]

18 01, 2017

CORRECTION: CVR Medical Granted IRB Approval by Thomas Jefferson

By | January 18th, 2017|Press Release|0 Comments

VANCOUVER, BC / ACCESSWIRE / January 18, 2017 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") issues correction on the following statement regarding the conduction of clinical trials, previously posted on January 12, 2017: CVR Medical Corp. is pleased to announce that its “Carotid Stenotic Scan (CSS)” device has received [...]

17 01, 2017

CVR Medical Partners With Hitachi For Development Of Processing Unit To Operate It’s CSS Device

By | January 17th, 2017|Press Release|0 Comments

VANCOUVER, BC / ACCESSWIRE / January 17, 2017 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") has chosen Hitachi High Technologies America, Inc. ("HTA") for the development and creation of the processing unit that will operate its “Carotid Stenotic Scan ("CSS")” device. The processor HTA has designed should enable the [...]